Affimed N.VのBeta
Affimed N.VのBetaは何ですか。
Affimed N.V.のBetaは1.05です。
Betaの定義は何ですか。
BETAは、株式が市場全体よりも多かれ少なかれ揮発性であるかどうかを示します。 1未満のベータは株式が市場よりも揮発性が低いことを示し、1より大きいベータは株式がより揮発性であることを示します。ボラティリティは、平均値周辺の価格の変動として測定されます。
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
NASDAQのセクタHealth CareにおけるBetaの企業と比べるAffimed N.V
Affimed N.Vは何をしますか。
affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli
Affimed N.Vと類似のbeta
- High TideのBetaは1.05です。
- Bausch Health CompaniesのBetaは1.05です。
- Clever LeavesのBetaは1.05です。
- PlexusのBetaは1.05です。
- Bechtle AGのBetaは1.05です。
- Senvest CapitalのBetaは1.05です。
- Affimed N.VのBetaは1.05です。
- Matthews InternationalのBetaは1.05です。
- VFのBetaは1.05です。
- Williamson Magor & CoのBetaは1.05です。
- Haldyn GlassのBetaは1.05です。
- Manhattan AssociatesのBetaは1.05です。
- Quartz Mountain ResourcesのBetaは1.05です。